The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 4, Pages 1260
Publisher
MDPI AG
Online
2018-04-24
DOI
10.3390/ijms19041260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
- (2018) Xavier Palomer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
- (2018) Shreekrishna Lamichane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease
- (2018) Michael B. Fessler PHARMACOLOGY & THERAPEUTICS
- The CAR agonist TCPOBOP inhibits lipogenesis and promotes fibrosis in the mammary gland of adolescent female mice
- (2018) Pengfei Xu et al. TOXICOLOGY LETTERS
- PPARγ Modulates Long Chain Fatty Acid Processing in the Intestinal Epithelium
- (2017) Kalina Duszka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melatonin prevents obesity through modulation of gut microbiota in mice
- (2017) Pengfei Xu et al. JOURNAL OF PINEAL RESEARCH
- DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2017) Jing Wang et al. Journal of the American Heart Association
- Microbiome Remodeling via the Montmorillonite Adsorption-Excretion Axis Prevents Obesity-related Metabolic Disorders
- (2017) Pengfei Xu et al. EBioMedicine
- The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
- (2016) Nathalie Hennuyer et al. ATHEROSCLEROSIS
- Small-molecule modulators of PXR and CAR
- (2016) Sergio C. Chai et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Distinct Roles of Transcription Factors KLF4, Krox20, and Peroxisome Proliferator-Activated Receptor γ in Adipogenesis
- (2016) Young-Kwon Park et al. MOLECULAR AND CELLULAR BIOLOGY
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- Preventive obesity agent montmorillonite adsorbs dietary lipids and enhances lipid excretion from the digestive tract
- (2016) Pengfei Xu et al. Scientific Reports
- PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
- (2016) Xiaomeng Feng et al. MEDICAL SCIENCE MONITOR
- A brief history of the discovery of PXR and CAR as xenobiotic receptors
- (2016) Jiong Yan et al. Acta Pharmaceutica Sinica B
- Liver X receptors at the intersection of lipid metabolism and atherogenesis
- (2015) Stephen D. Lee et al. ATHEROSCLEROSIS
- Obesity and Atherosclerosis: Mechanistic Insights
- (2015) Fina Lovren et al. CANADIAN JOURNAL OF CARDIOLOGY
- Targeting xenobiotic receptors PXR and CAR in human diseases
- (2015) Monimoy Banerjee et al. DRUG DISCOVERY TODAY
- Potent peroxisome proliferator-activated receptor- agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome
- (2015) A. V. Khera et al. EUROPEAN HEART JOURNAL
- Small-molecule modulators of the constitutive androstane receptor
- (2015) Milu T Cherian et al. Expert Opinion on Drug Metabolism & Toxicology
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- CAR Suppresses Hepatic Gluconeogenesis by Facilitating the Ubiquitination and Degradation of PGC1α
- (2015) Jie Gao et al. MOLECULAR ENDOCRINOLOGY
- Families of Nuclear Receptors in Vertebrate Models: Characteristic and Comparative Toxicological Perspective
- (2015) Yanbin Zhao et al. Scientific Reports
- Deciphering the roles of the constitutive androstane receptor in energy metabolism
- (2014) Jiong Yan et al. ACTA PHARMACOLOGICA SINICA
- Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches
- (2014) Fabian Sanchis-Gomar et al. CURRENT PHARMACEUTICAL DESIGN
- Editorial (Thematic Issue: Mitochondrial Biogenesis: Pharmacological Approaches)
- (2014) Teresa Valero CURRENT PHARMACEUTICAL DESIGN
- Liver X Receptor: A Cardinal Target for Atherosclerosis and Beyond
- (2014) Mihir Parikh et al. Journal of Atherosclerosis and Thrombosis
- Liver X receptors in lipid metabolism: opportunities for drug discovery
- (2014) Cynthia Hong et al. NATURE REVIEWS DRUG DISCOVERY
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- Activation of the constitutive androstane receptor inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis in human hepatocytes
- (2014) Caitlin Lynch et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Integrated physiology and systems biology of PPARα
- (2014) Sander Kersten Molecular Metabolism
- Honokiol: A non-adipogenic PPARγ agonist from nature
- (2013) Atanas G. Atanasov et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARγ) agonist with potent glucose-lowering properties
- (2013) C. Weidner et al. DIABETOLOGIA
- Role of the constitutive androstane receptor in obesity and type 2 diabetes: a case study of the endobiotic function of a xenobiotic receptor
- (2013) Mengxi Jiang et al. DRUG METABOLISM REVIEWS
- Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond
- (2013) Xiaojuan Chai et al. Expert Opinion on Drug Metabolism & Toxicology
- Liver X receptor modulators: a review of recently patented compounds (2009 – 2012)
- (2013) Jon Loren et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Targeting liver X receptors in inflammation
- (2013) Knut R Steffensen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Concurrent Activation of Liver X Receptor and Peroxisome Proliferator-Activated Receptor Alpha Exacerbates Hepatic Steatosis in High Fat Diet-Induced Obese Mice
- (2013) Mingming Gao et al. PLoS One
- PPAR-α as a Key Nutritional and Environmental Sensor for Metabolic Adaptation
- (2013) Alejandra V. Contreras et al. Advances in Nutrition
- Atherosclerosis as an Inflammatory Disease
- (2012) Antonino Tuttolomondo et al. CURRENT PHARMACEUTICAL DESIGN
- Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)
- (2012) Christina Lamers et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist
- (2012) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amorfrutins are potent antidiabetic dietary natural products
- (2012) C. Weidner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPARs: Fatty acid sensors controlling metabolism
- (2012) Lars la Cour Poulsen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- PPARs at the crossroads of lipid signaling and inflammation
- (2012) Walter Wahli et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Atherosclerosis: lessons from LXR and the intestine
- (2012) Barbara Bonamassa et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Liver X receptor biology and pharmacology: new pathways, challenges and opportunities
- (2012) Tomas Jakobsson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Suppression of Chronic Damage in Renal Allografts by Liver X Receptor (LXR) Activation
- (2011) Eva Kiss et al. AMERICAN JOURNAL OF PATHOLOGY
- Constitutive Androstane Receptor Activation Decreases Plasma Apolipoprotein B–Containing Lipoproteins and Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice
- (2011) Anne-Laure Sberna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- DBZ Blocks LPS-induced Monocyte Activation and Foam Cell Formation via Inhibiting Nuclear Factor-ĸB
- (2011) Xinni Xie et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Liver X Receptors in Atherosclerosis and Inflammation
- (2011) Seung-Soon Im et al. CIRCULATION RESEARCH
- Functional crosstalk of CAR–LXR and ROR–LXR in drug metabolism and lipid metabolism
- (2010) Lei Xiao et al. ADVANCED DRUG DELIVERY REVIEWS
- Intestinal Specific LXR Activation Stimulates Reverse Cholesterol Transport and Protects from Atherosclerosis
- (2010) Giuseppe Lo Sasso et al. Cell Metabolism
- Pregnane X Receptor and Constitutive Androstane Receptor at the Crossroads of Drug Metabolism and Energy Metabolism
- (2010) J. Gao et al. DRUG METABOLISM AND DISPOSITION
- Liver X receptor modulators: a review of recently patented compounds (2007 – 2009)
- (2010) Xiaolin Li et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Endogenous Ligands for Nuclear Receptors: Digging Deeper
- (2010) Michael Schupp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice
- (2010) Anne Laure Sberna et al. JOURNAL OF HEPATOLOGY
- A Functional Cross-Talk between Liver X Receptor- and Constitutive Androstane Receptor Links Lipogenesis and Xenobiotic Responses
- (2010) Y. Zhai et al. MOLECULAR PHARMACOLOGY
- PPARαin Obesity: Sex Difference and Estrogen Involvement
- (2010) Michung Yoon PPAR Research
- Functional and genetic analysis in type 2 diabetes of Liver X receptor alleles – a cohort study
- (2009) Ingrid Dahlman et al. BMC Medical Genetics
- Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes
- (2009) Bingning Dong et al. HEPATOLOGY
- The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin Sensitivity
- (2009) Jie Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR-623, a Novel Liver X-Receptor Agonist, in Healthy Participants
- (2009) Arie Katz et al. JOURNAL OF CLINICAL PHARMACOLOGY
- LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse
- (2009) Elaine M. Quinet et al. JOURNAL OF LIPID RESEARCH
- The role of PPARα in lipid metabolism and obesity: Focusing on the effects of estrogen on PPARα actions
- (2009) Michung Yoon PHARMACOLOGICAL RESEARCH
- Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation
- (2009) David Bishop-Bailey et al. PHARMACOLOGY & THERAPEUTICS
- Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease
- (2009) B. Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PXR and CAR in energy metabolism
- (2009) Taira Wada et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- Regulatory Cross-Talk between Drug Metabolism and Lipid Homeostasis: Constitutive Androstane Receptor and Pregnane X Receptor Increase Insig-1 Expression
- (2008) A. Roth et al. MOLECULAR PHARMACOLOGY
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- The Role of PPARs in Cancer
- (2008) Keisuke Tachibana et al. PPAR Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More